Covered recipient · General Payments record
RICHARD ALLEN COOK
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$491.18
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $252.35 | 17 |
| Travel and Lodging | $118.60 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $146.99 | 11 |
| Acerta Pharma LLC | $118.60 | 2 |
| Novo Nordisk AS | $59.03 | 3 |
| ABBVIE INC. | $46.33 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.40 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103499944 | CMS |
| ABBVIE INC. | $13.72 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103499946 | CMS |
| ABBVIE INC. | $14.21 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103499948 | CMS |
| AstraZeneca Pharmaceuticals LP | $40.00 | 09/20/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104675429 | CMS |
| AstraZeneca Pharmaceuticals LP | $78.60 | 09/20/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1105676567 | CMS |
| Novo Nordisk Inc | $21.93 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097626617 | CMS |
| Novo Nordisk Inc | $16.84 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096919802 | CMS |
| Novo Nordisk Inc | $20.26 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097607030 | CMS |
| PFIZER INC. | $11.60 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131798775 | CMS |
| PFIZER INC. | $11.69 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131823602 | CMS |
| PFIZER INC. | $17.40 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131804371 | CMS |
| PFIZER INC. | $12.56 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131809559 | CMS |
| PFIZER INC. | $3.80 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131805191 | CMS |
| PFIZER INC. | $17.25 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131820840 | CMS |
| PFIZER INC. | $13.23 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131818640 | CMS |
| PFIZER INC. | $13.95 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131796622 | CMS |
| PFIZER INC. | $20.30 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130891240 | CMS |
| PFIZER INC. | $11.16 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131008353 | CMS |
| PFIZER INC. | $14.05 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131152676 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.